Korea Ratifies Free Trade Agreement With U.S., Pleasing Pharma Industry
This article was originally published in PharmAsia News
Executive Summary
Patent linkage provisions among key benefits for the pharmaceutical industry.
You may also be interested in...
Korean And U.S. Presidents Welcome Long-Awaited Korea-U.S. FTA Ratification; Now Eyes on Seoul
SEOUL -Korean President Lee Myung-bak and U.S. President Barack Obama both welcomed and celebrated the U.S. Congress's ratification of the Free Trade Agreement, saying the historic free trade deal will benefit both countries. But ratification is still needed in South Korea, and political maneuvering by the country's ruling and opposition parties may delay the process
Pharma Industry Applauds Final Push For Ratification Of Korea-U.S. FTA, Patent Linkage, Transparency, Among Benefits
SEOUL - South Korean Prime Minister Kim Hwang-sik called on cabinet ministers to ratify Korea's free trade agreement with the United States during the country's National Assembly session Oct. 4
Early-Stage Idiopathic Pulmonary Fibrosis (IPF) Candidates Race to Phase III
Multiple IPF drugs are being rushed into Phase III based on early-stage signals of efficacy and safety presented at the ATS meeting. Scrip spoke with the University of Pittsburgh's Kevin Gibson about the candidates, trial design, combination therapy and limitations of current therapy.